346 related articles for article (PubMed ID: 12139457)
1. The effect of a phosphodiester linking group on albumin binding, blood half-life, and relaxivity of intravascular diethylenetriaminepentaacetato aquo gadolinium(III) MRI contrast agents.
McMurry TJ; Parmelee DJ; Sajiki H; Scott DM; Ouellet HS; Walovitch RC; Tyeklár Z; Dumas S; Bernard P; Nadler S; Midelfort K; Greenfield M; Troughton J; Lauffer RB
J Med Chem; 2002 Aug; 45(16):3465-74. PubMed ID: 12139457
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity.
Parac-Vogt TN; Kimpe K; Laurent S; Vander Elst L; Burtea C; Chen F; Muller RN; Ni Y; Verbruggen A; Binnemans K
Chemistry; 2005 May; 11(10):3077-86. PubMed ID: 15776492
[TBL] [Abstract][Full Text] [Related]
3. Albumin binding, relaxivity, and water exchange kinetics of the diastereoisomers of MS-325, a gadolinium(III)-based magnetic resonance angiography contrast agent.
Caravan P; Parigi G; Chasse JM; Cloutier NJ; Ellison JJ; Lauffer RB; Luchinat C; McDermid SA; Spiller M; McMurry TJ
Inorg Chem; 2007 Aug; 46(16):6632-9. PubMed ID: 17625839
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Characterization, and Biodistribution of a Dinuclear Gadolinium Complex with Improved Properties as a Blood Pool MRI Agent.
La Cava F; Fringuello Mingo A; Miragoli L; Terreno E; Cappelletti E; Lattuada L; Poggi L; Colombo Serra S
ChemMedChem; 2018 Apr; 13(8):824-834. PubMed ID: 29442438
[TBL] [Abstract][Full Text] [Related]
5. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
6. Structural, kinetic, and thermodynamic characterization of the interconverting isomers of MS-325, a gadolinium(III)-based magnetic resonance angiography contrast agent.
Tyeklar Z; Dunham SU; Midelfort K; Scott DM; Sajiki H; Ong K; Lauffer RB; Caravan P; McMurry TJ
Inorg Chem; 2007 Aug; 46(16):6621-31. PubMed ID: 17625838
[TBL] [Abstract][Full Text] [Related]
7. How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity.
Port M; Corot C; Violas X; Robert P; Raynal I; Gagneur G
Invest Radiol; 2005 Sep; 40(9):565-73. PubMed ID: 16118549
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents.
Laurent S; Elst LV; Muller RN
Contrast Media Mol Imaging; 2006; 1(3):128-37. PubMed ID: 17193689
[TBL] [Abstract][Full Text] [Related]
9. Paramagnetic liposomes containing amphiphilic bisamide derivatives of Gd-DTPA with aromatic side chain groups as possible contrast agents for magnetic resonance imaging.
Parac-Vogt TN; Kimpe K; Laurent S; Piérart C; Elst LV; Muller RN; Binnemans K
Eur Biophys J; 2006 Jan; 35(2):136-44. PubMed ID: 16217648
[TBL] [Abstract][Full Text] [Related]
10. The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates.
Caravan P; Cloutier NJ; Greenfield MT; McDermid SA; Dunham SU; Bulte JW; Amedio JC; Looby RJ; Supkowski RM; Horrocks WD; McMurry TJ; Lauffer RB
J Am Chem Soc; 2002 Mar; 124(12):3152-62. PubMed ID: 11902904
[TBL] [Abstract][Full Text] [Related]
11. MS-325: albumin-targeted contrast agent for MR angiography.
Lauffer RB; Parmelee DJ; Dunham SU; Ouellet HS; Dolan RP; Witte S; McMurry TJ; Walovitch RC
Radiology; 1998 May; 207(2):529-38. PubMed ID: 9577506
[TBL] [Abstract][Full Text] [Related]
12. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents.
Giesel FL; von Tengg-Kobligk H; Wilkinson ID; Siegler P; von der Lieth CW; Frank M; Lodemann KP; Essig M
Invest Radiol; 2006 Mar; 41(3):222-8. PubMed ID: 16481904
[TBL] [Abstract][Full Text] [Related]
13. Redox-sensitive contrast agents for MRI based on reversible binding of thiols to serum albumin.
Raghunand N; Jagadish B; Trouard TP; Galons JP; Gillies RJ; Mash EA
Magn Reson Med; 2006 Jun; 55(6):1272-80. PubMed ID: 16700014
[TBL] [Abstract][Full Text] [Related]
14. The presence of halide salts influences the non-covalent interaction of MRI contrast agents and human serum albumin.
Henrotte V; Muller RN; Bartholet A; Elst LV
Contrast Media Mol Imaging; 2007; 2(5):258-61. PubMed ID: 18058865
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium(III) di- and tetrachelates designed for in vivo noncovalent complexation with plasma proteins: a novel molecular design for blood pool MRI contrast enhancing agents.
Martin VV; Ralston WH; Hynes MR; Keana JF
Bioconjug Chem; 1995; 6(5):616-23. PubMed ID: 8974462
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of two new gadolinium chelates as contrast agents for MRI.
Wiegers CB; Welch MJ; Sharp TL; Brown JJ; Perman WH; Sun Y; Motekaitis RJ; Martell AE
Magn Reson Imaging; 1992; 10(6):903-11. PubMed ID: 1461088
[TBL] [Abstract][Full Text] [Related]
17. Maximizing the relaxivity of Gd-complex by synergistic effect of HSA and carboxylfullerene.
Zhen M; Zheng J; Ye L; Li S; Jin C; Li K; Qiu D; Han H; Shu C; Yang Y; Wang C
ACS Appl Mater Interfaces; 2012 Jul; 4(7):3724-9. PubMed ID: 22704586
[TBL] [Abstract][Full Text] [Related]
18. Non-ionic bulky Gd(III) DTPA-bisamide complexes as potential contrast agents for magnetic resonance imaging.
Bligh SW; Chowdhury AH; Kennedy D; Luchinat C; Parigi G
Magn Reson Med; 1999 Apr; 41(4):767-73. PubMed ID: 10332853
[TBL] [Abstract][Full Text] [Related]
19. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
